Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Scientists at Indiana University, Medical Department detail research in breast cancer
May 28th, 2009
"- Intratumoral heterogeneity of HER2 gene amplification has been well documented and represents sub-clonal diversity within the tumor. The reported incidence of intratumor HER2 amplification genetic heterogeneity ranges in the literature from approximately 5% to 30%," scientists writing in the journal Archives of Pathology & Laboratory Medicine report. "The presence of HER2 genetic heterogeneity may increase subjectivity in HER2 interpretation by the pathologist. - To define HER2 genetic heterogeneity and to provide practice guidelines for examining and reporting breast tumors with genetic heterogeneity for improvement of HER2 testing in breast cancer. - We...
Source: Women's Health Weekly (2009-05-28)
|
